Scott S. Emerson

机构：University of Washington, Cancer Research And Biostatistics · ORCID：0000-0002-2695-0165

发表论文 215 篇 · 总被引 18491 次 · h-index 59

代表论文

• Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023 · New England Journal of Medicine · 被引 3061)
• Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (2025 · New England Journal of Medicine · 被引 383)
• Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials (2024 · The Lancet · 被引 306)
• Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial (2024 · The Lancet · 被引 275)
• Evaluation of Aducanumab for Alzheimer Disease (2021 · JAMA · 被引 245)
• Revisiting FDA Approval of Aducanumab (2021 · New England Journal of Medicine · 被引 166)